Dipanwita Das, CEO of Sorcero, has been honored as one of only three female founders in life sciences AI included in the 2026 100 Women in AI list.
This recognition highlights Das's significant contributions to the field, placing her alongside leaders from major AI companies like OpenAI and Google. Sorcero, under her leadership, has developed an AI platform that addresses critical challenges in healthcare by enhancing the delivery of therapies to patients. The platform boasts impressive metrics, including a 96.1% clinical accuracy rate and a reduction in data analysis time by over 72%, which is crucial for expediting patient access to effective treatments.
Das emphasized the importance of timely access to scientific data, particularly for complex therapies in development. She noted that publishing clinical trial results sooner can drastically reduce wait times for patients seeking potentially life-changing treatments. The focus on building AI solutions tailored for the medical field is essential for ensuring patient safety and regulatory compliance.
This accolade comes after a successful year for Sorcero, marked by a substantial funding round and multiple industry awards, underscoring the company's impact and innovation in the life sciences sector.